博拓生物

688767 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

5.0B ($723.3M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

559.0M

Net Income

167.0M

Gross Margin

N/A

Op. Margin

34.5%

Net Margin

29.9%

ROE

6.9%

ROA

6.4%

D/E

0.08

Dividend Yield

N/A

EPS

1.61

Current Ratio

10.49

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immunoassay rapid test kits; and other rapid testing kits. In addition, the company is widely utilized across various medical institutions, judicial testing systems, third-party testing organizations, Cente...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 博拓生物

Ticker	688767
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业